心脏移植：还有存在的意义吗？

Cardiac transplantation: any role left?

作者信息

Cadeiras Martin, von Bayern Manuel Prinz, Deng Mario C

机构信息

College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

出版信息

Heart Fail Clin. 2007 Jul;3(3):321-47. doi: 10.1016/j.hfc.2007.04.004.

DOI:10.1016/j.hfc.2007.04.004

PMID:17723940

Abstract

The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.

摘要

作者们分析了在当前复杂技术时代心脏移植是否仍具有作用这一问题。为实现这一目标，作者们首先讨论了目前可用于终末期心力衰竭患者的不同治疗方式的已知益处，包括药物治疗、电生理治疗、高风险手术策略、机械循环支持装置植入治疗以及心脏移植。然后，作者们评估了该领域当前的发展情况以及未来的前景，这些可能会影响心脏移植仍然作为终末期心力衰竭首选治疗方式的可能性。